US Stock MarketDetailed Quotes
SSKN Strata Skin Sciences
- 2.990
- -0.090-2.92%
Close Dec 3 16:00 ET
12.47MMarket Cap-1150P/E (TTM)
3.170High2.990Low1.57KVolume3.019Open3.080Pre Close4.78KTurnover0.10%Turnover RatioLossP/E (Static)4.17MShares6.89952wk High1.33P/B4.72MFloat Cap2.51352wk Low--Dividend TTM1.58MShs Float6120.000Historical High--Div YieldTTM5.84%Amplitude2.513Historical Low3.045Avg Price1Lot Size
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Strata Skin Sciences Stock Forum
1 MINUTE AGO, 8:15 AM EST
VIA GLOBENEWSWIRE
HORSHAM, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces t...
STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group
STRATA Skin Sciences (NASDAQ: SSKN) announces a favorable court order in its complaint against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group. The order, issued by the US District Court for Eastern Pennsylvania, enjoins LaserOptek and Pinnacle from marketing Pallas lasers with claims about CPT Codes 9692...
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
STRATA Skin Sciences (NASDAQ: SSKN) has received approval for its XTRAC Momentum™ 1.0 device from Japan's Ministry of Health, Labor and Welfare. The device, initially launched in the U.S. in early 2022, will be commercially rolled out in Japan through JMEC Co., , STRATA's strategic partner and distributor. STRATA's excimer devices are currently used in over 300 Japanese hospitals an...
STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found Safe and Effective in Study Published in Peer Reviewed Journal
STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
Positive
Estimated Q2 2024 revenue between $8.0 million and $8.4 million.
Growth in the domestic installed base of TheraClear®X devices from 104 to 117 units.
Cash, cash equivalents, and restricted cash of $6.8 million.
Strategic initiatives to drive device utilization and direct-to-consumer activities.
Increased media coverage potentially enhancing market awareness.
Negative
Decli...
$Volcon (VLCN.US)$
$DBV Technologies (DBVT.US)$
$Strata Skin Sciences (SSKN.US)$
Recap NEWS this MORNING
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClearX Devices as of March 31, 2024
NEWS
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
$VS MEDIA Holdings (VSME.US)$ Has made runs at the beginning of every month since its debut. This also will be a quarter since its debut and short sellers like to cover at these intervals. Needs to stay above .3490. If it can break over .50 then its toughest resistance will be at .88 but at .84 is 100% profit.
$Strata Skin Sciences (SSKN.US)$ Announced news at the bell Friday. Stock ran almost to a new one year high before pulling all the wsy b...
No comment yet